Price updated from 10:59 am

DuPont's  (DD - Get Report) nutrition and bioscience business may be up for sale and Amsterdam's Royal DSM may want to buy it, according to a report from Bloomberg.

The business could be valued at $25 billion, people who asked not to be identified told Bloomberg. 

The specialty chemicals maker has been considering the sale or spinoff of its nutrition business, and has been in the process of selecting advisers to sort out offers for the division for some time, according to confidential sources.

In August, Bloomberg said that DuPont wanted to rid itself of the arm, and may be looking into a Reverse Morris Trust, a tax-free merger, as well. 

Shares of DuPont fell 1.41% to $72.50 on Monday.

DuPont is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells DD? Learn more now.